全球POC血糖測試市場規模、佔有率、成長分析（按配方、最終用途）- 產業預測，2023-2030年

Global Point-of-care Glucose Testing Market Size, Share, Growth Analysis, By Prescription(OTC testing, and Prescription-based testing), By End-use(Hospitals, Diagnostic centers) - Industry Forecast 2023-2030

出版日期: 2023年11月17日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2021年全球POC血糖檢測市場規模為31.7億美元，預測期內（2023-2030年）年複合成長率為4.2%，從2022年的33億美元增至2030年的45.9億美元。預計將成長至10,000,000 美元。

由於糖尿病盛行率不斷上升以及需要定期監測血糖以進行有效的疾病管理，醫療保健領域的全球 POC 血糖檢測市場快速成長。該市場包括使用可提供即時結果的攜帶式血糖測試設備，使醫療保健專業人員和個人能夠在治療時方便地監測血糖值。 POC 血糖檢測的優點包括快速得出結果，改善病患治療結果並降低醫療成本。其主要目的是促進及時、準確的血糖監測，特別是對於糖尿病患者來說，使醫療保健專業人員能夠就治療計劃和劑量調整做出資訊的決定，並且可以快速做出決定。此外，即時檢測有助於早期發現、監測和干涉，以改善糖尿病管理，透過提供即時資訊來管理個人健康，增強個人能力。全球糖尿病盛行率的不斷上升以及人們對定期血糖監測重要性的認知不斷增強，推動了該市場的發展。雖然有成長潛力，但測試設備的成本以及對精度和準確度的需求等問題是市場開拓的考慮因素。也就是說，POC 葡萄糖檢測市場提供了重要的成長和創新機會。

POC 血糖檢測全球細分市場分析

全球 POC 血糖檢測市場按處方、最終用途和地區細分。按處方箋，市場分為非處方藥檢測和處方箋檢測。依最終用途分類，市場分為醫院、診斷中心、實驗室、居家照護環境等。依地區分類，市場分為北美、歐洲、亞太地區、中東和非洲以及拉丁美洲。

全球POC血糖檢測市場的促進因素

全球 POC 血糖檢測市場的關鍵促進因素是全球糖尿病盛行率的不斷上升。糖尿病盛行率的不斷上升，加上定期和快速血糖監測的需求，推動對即時檢測解決方案的需求。在照護端獲取血糖測量的便利性和速度有助於更好的疾病管理和改善患者的治療結果。

全球POC血糖檢測市場的抑制因素

市場的潛在抑制因素之一是 POC 血糖檢測設備的高成本。雖然這些設備提供便利和即時的效果，但初始投資和持續成本對於一些醫療保健提供者和患者來說可能是一個挑戰。負擔能力和償付問題可能會限制這些技術的普及，特別是在資源有限的地區。

全球POC血糖檢測市場趨勢

全球 POC 血糖檢測市場的新興趨勢之一是數位健康技術和連接功能的整合。許多現代血糖測試設備都包含藍牙和其他無線技術，可將資料無縫傳輸到智慧型手機和其他醫療保健平台。這種整合促進了患者和醫療保健提供者之間的遠端監控、資料管理和即時通訊，有助於更個人化和主動的糖尿病管理。

執行摘要
調查方法
母市場分析
主要市場考察
- 技術分析
- 價格分析
- 供應鏈分析
- 價值鏈分析
- 市場生態系統
- 智慧財產權分析
- 貿易分析
- Start-Ups分析
- 原料分析
- 創新矩陣
- 研發線產品分析
- 總體經濟指標
- 主要投資分析
- 關鍵成功因素
- 競爭程度
市場動態及展望
- 市場動態
  - 促進因素
  - 機會
  - 抑制因素
  - 課題
- 監管形勢
- 波特的分析
- 對未來顛覆的特別見解
全球 POC 血糖檢測市場：依處方分類
- 市場概況
- 場外測試
- 根據處方進行測試
全球 POC 血糖測試市場：依最終用途分類
- 市場概況
- 醫院
- 診斷中心
- 研究
- 居家照護環境
- 其他
全球POC血糖檢測市場規模（依地區）
- 市場概況
- 北美洲
  - 美國
  - 加拿大
- 歐洲
  - 德國
  - 西班牙
  - 法國
  - 英國
  - 其他歐洲國家地區
- 亞太地區
  - 中國
  - 印度
  - 日本
  - 韓國
  - 其他亞太地區
- 拉丁美洲
  - 巴西
  - 其他拉丁美洲地區
- 中東和非洲（MEA）
  - 海灣合作理事會國家
  - 南非
  - 其他中東、非洲地區
競爭形勢
- 前5名企業對比
- 主要企業市場定位（2021年）
- 主要市場參與者所採取的策略
- 關鍵成功策略
- 近期市集活動
- 主要企業市場佔有率（2021年）
主要企業簡介
- Abbott（US）
- Dexcom（US）
- Roche（Switzerland）
- Ascensia Diabetes Care（Switzerland）
- LifeScan（US）
- Medtronic（US）
- Ypsomed（Switzerland）
- Animas（US）
- Insulet（US）
- Bayer（Germany）
- Nipro（Japan）
- Terumo（Japan）
- Arkray（Japan）
- Acon Laboratories（US）
- Freestyle（US）
- One Touch（US）
- Accu-Chek（Germany）
- Dario（US）
- iHealth（China）
- FreeStyle Libre（UK）

簡介目錄

Product Code: SQMIG15E2398

Global Point-of-care glucose testing Market size was valued at USD 3.17 Billion in 2021 and is poised to grow from USD 3.3 Billion in 2022 to USD 4.59 Billion by 2030, at a CAGR of 4.2% during the forecast period (2023-2030).

The global point-of-care glucose testing market is experiencing rapid growth within the healthcare sector, driven by the escalating prevalence of diabetes and the necessity for regular glucose monitoring for effective disease management. This market involves the utilization of portable glucose testing devices that offer immediate results, enabling both healthcare professionals and individuals to conveniently monitor blood glucose levels at the point of care. The advantages of point-of-care glucose testing include swift results, enhanced patient outcomes, and reduced healthcare costs. Its primary objective is to facilitate timely and accurate glucose monitoring, particularly for individuals managing diabetes, allowing healthcare professionals to make informed decisions regarding treatment plans and medication dosages adjustments promptly. Furthermore, point-of-care testing empowers individuals by providing real-time information to take control of their health, promoting early detection, monitoring, and intervention for improved diabetes management. The market is fueled by the increasing global incidence of diabetes, coupled with growing awareness about the importance of regular glucose monitoring. Despite its growth potential, challenges such as the cost of testing devices and the need for precision and accuracy pose considerations for the market's development. Nevertheless, the point-of-care glucose testing market presents significant opportunities for growth and innovation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Point-of-care glucose testing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Point-of-care glucose testing Market Segmental Analysis

The global point-of-care glucose testing market is segmented on the prescription, end-use, and region. By prescription, the market is segmented into OTC testing, Prescription-based testing. In terms of segmentation by end-use, the market is segmented into hospitals, diagnostic centers, research laboratories, home-care settings, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers in the Global Point-of-care glucose testing Market

A significant driver for the global point-of-care glucose testing market is the growing prevalence of diabetes worldwide. The increasing incidence of diabetes, coupled with the need for regular and rapid glucose monitoring, has driven the demand for point-of-care testing solutions. The convenience and speed of obtaining glucose readings at the point of care contribute to better disease management and improved patient outcomes.

Restraints in the Global Point-of-care glucose testing Market

A potential restraint for the market is the high cost associated with point-of-care glucose testing devices. While these devices offer convenience and immediate results, the initial investment and ongoing costs may pose a challenge for some healthcare providers and patients. Affordability and reimbursement issues can limit the widespread adoption of these technologies, especially in regions with resource constraints.

Market Trends of the Global Point-of-care glucose testing Market

An emerging trend in the global point-of-care glucose testing market is the integration of digital health technologies and connectivity features. Many modern glucose testing devices are equipped with Bluetooth or other wireless technologies, allowing seamless data transfer to smartphones or other healthcare platforms. This integration facilitates remote monitoring, data management, and real-time communication between patients and healthcare providers, contributing to more personalized and proactive diabetes management.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
  - Drivers
  - Opportunities
  - Restraints
  - Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
  - Drivers
  - Opportunities
  - Restraints
  - Challenges
- Regulatory Landscape
- Porters Analysis
  - Competitive rivalry
  - Threat of Substitute Products
  - Bargaining Power of Buyers
  - Threat of New Entrants
  - Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
  - Political Impact
  - Economic Impact
  - Social Impact
  - Technical Impact
  - Environmental Impact
  - Legal Impact
Global Point-of-care Glucose Testing Market by Prescription
- Market Overview
- OTC testing
- and Prescription-based testing
Global Point-of-care Glucose Testing Market by End-use
- Market Overview
- Hospitals
- Diagnostic centers
- Research laboratories
- Home-care settings
- and Others
Global Point-of-care Glucose Testing Market Size by Region
- Market Overview
- North America
  - USA
  - Canada
- Europe
  - Germany
  - Spain
  - France
  - UK
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - South Korea
  - Rest of Asia-Pacific
- Latin America
  - Brazil
  - Rest of Latin America
- Middle East & Africa (MEA)
  - GCC Countries
  - South Africa
  - Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
  - By Development
  - By Company
  - By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Abbott (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Dexcom (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Roche (Switzerland)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Ascensia Diabetes Care (Switzerland)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- LifeScan (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Medtronic (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Ypsomed (Switzerland)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Animas (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Insulet (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Bayer (Germany)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Nipro (Japan)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Terumo (Japan)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Arkray (Japan)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Acon Laboratories (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Freestyle (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- One Touch (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Accu-Chek (Germany)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Dario (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- iHealth (China)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- FreeStyle Libre (UK)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments